S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|NW Bio Takes Next Steps In Moving Forward With Its Phase III Brain Cancer Trial In Europe (2013/2/15)|
|Medtentia International and clinicalprojects international Tap BioClinica for Express EDC, Data Management, and Centralized Imaging Reads (2013/3/4)|
|Kesselrun Announces Drilling Results from Bluffpoint Project, Amendment to Bluffpoint Option Agreement and Vend In of Three New Projects (2013/4/30)|
|Japanese CRO CAC EXICARE Teams with Medidata to Improve Customers’ Clinical Trial Efficiency and Effectiveness Through Cloud Technology (2013/4/16)|
|New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry (2013/4/22)|
|Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research (2013/5/21)|
|SANUWAVE Health Receives Full Approval From the FDA to Conduct the dermaPACE Pivotal Clinical Trial (2013/3/13)|
|Agere Adds New Leadership Roles in Scientific and Business Areas (2013/3/12)|
|OnQ Research Selects Merge eClinical OS(TM) for Electronic Data Capture (2013/5/8)|
|Cubist Obtains Remaining Rights to Ceftolozane from Astellas (2013/3/11)|
Click above to view more mutual fund data and stats for cro - Canadian Arrow Mines Limited.